A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2009
12/30/2009	WO2009155789A1 Polypeptides and derivatives thereof that inhibit hiv infection
12/30/2009	WO2009155711A1 Analysis of lactobacillus acidophilus la-5 signal interference molecules
12/30/2009	WO2009155665A1 Methods and compositions for treating pathological infections
12/30/2009	WO2009126346A3 Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins
12/30/2009	WO2009117831A9 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
12/30/2009	WO2009113033A3 Linear and cyclic guanidine derivatives, method of preparation and uses thereof
12/30/2009	WO2009112678A3 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
12/30/2009	EP2138582A2 DNA and specific peptides or proteins of bacteria of the species neisseria meningitidis, methods for obtaining same and their biological applications
12/30/2009	EP2138187A1 Probiotics, secretory IgA and infection
12/30/2009	EP2138186A1 Probiotics, secretory IgA and inflammation
12/30/2009	EP2138171A1 Veterinarian compositions containing terpinen-4-ol for the treatment and prevention of mastitis
12/30/2009	EP2138163A2 Suppository formulations comprising tenofovir or tenofovir disoproxil
12/30/2009	EP2138162A2 Gel comprising tenofovir or tenofovir disoproxil
12/30/2009	EP2137214A1 Novel human anti-r7v antibodies and uses thereof
12/30/2009	EP2137196A1 Tricyclic nitrogen containing compounds as antibacterial agents
12/30/2009	EP2137172A1 Phenothiazin derivatives for antiviral treatments
12/30/2009	EP2137143A1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
12/30/2009	EP2136836A2 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
12/30/2009	EP2136816A2 Oleyl phosphocholine
12/30/2009	EP2136812A1 Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
12/30/2009	EP2136808A2 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
12/30/2009	EP2136807A1 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis
12/30/2009	EP2136806A1 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria
12/30/2009	EP2136802A2 Use of fungicides for treating fish mycoses
12/30/2009	EP1448567B1 Method for the preparation of hexahydro-furo 2,3-b furan-3-ol
12/30/2009	EP1430019B1 Sphingolipids
12/30/2009	CN101612402A Interferon antagonist and use of Flt3L interferon
12/30/2009	CN100575491C Trans menbrance type and secretory type HIV Gag antigen code gene and AIDS vaccine containing said gene
12/30/2009	CN100575482C Novel cytokine zcytor17 ligand
12/30/2009	CN100575359C Rana grahami boulenger antibiotic peptide and application thereof
12/30/2009	CN100575358C Honeysuckle extract and its preparation method and application
12/30/2009	CN100575335C Amino-propanol derivatives
12/30/2009	CN100574805C Therapeutic infusion containing fructose
12/30/2009	CN100574803C Use of immunoregulation antibody for the treatment of neoplastic disorders
12/30/2009	CN100574795C Chinese traditional medicine for treating myocarditis
12/30/2009	CN100574784C Orally taken traditional Chinese medicine composition for treating bacillary dysentery
12/30/2009	CN100574780C Compositions against inflammatory processes
12/30/2009	CN100574775C Rabdosia serra (Maxim.) hara extract, preparing process and application thereof
12/30/2009	CN100574773C Oral medicine of combined traditional Chinese and Western medicine for treating bacteria finrot disease of grass carp
12/30/2009	CN100574771C Medicine for treating women's genital system disease
12/30/2009	CN100574768C An anticancer medicinal composition, preparing method and use thereof
12/30/2009	CN100574764C Anti-hepatitis pharmaceutical composition and preparation process thereof
12/30/2009	CA2765298A1 Probiotic bacterial molecules and their use in methods to treat/prvent infection by harmful bacteria and to provide nutritional health
12/30/2009	CA2763536A1 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
12/30/2009	CA2729546A1 Compounds and compositions as kinase inhibitors
12/30/2009	CA2729545A1 Regulated genetic suicide mechanism compositions and methods
12/30/2009	CA2728693A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives
12/30/2009	CA2727303A1 Probiotics, secretory iga and infection
12/30/2009	CA2727300A1 Probiotics, secretory iga and inflammation
12/30/2009	CA2726465A1 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
12/29/2009	US7638679 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver.
12/29/2009	US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/29/2009	US7638546 Imidazolyl derivatives
12/29/2009	US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders
12/29/2009	US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/29/2009	US7638528 Drug delivery agent containing an anticarcinogenic agent such as mitoxanthrone, doxorubicin, methotrexate etc. covalently linked to a compound via an ester, amido or carabamte linkage to the S, O or amino group of the compound
12/29/2009	US7638522 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
12/29/2009	US7638502 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation
12/29/2009	US7638494 G-type peptides to ameliorate atherosclerosis
12/29/2009	US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
12/29/2009	US7638269 Viral capsid assembly intermediates and methods of production
12/29/2009	CA2563761C Inhibitors of the hiv integrase enzyme
12/29/2009	CA2477851C Small molecule entry inhibitors
12/29/2009	CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/29/2009	CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
12/29/2009	CA2447521C Delivery of antihistamines through an inhalation route
12/29/2009	CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors
12/29/2009	CA2419258C Intermediates in cephalosporin production
12/29/2009	CA2415683C Indoloquinazolinones
12/29/2009	CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels
12/29/2009	CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules
12/24/2009	US20090318711 Non-Covalent Inhibitors of AmpC ß-Lactamase
12/24/2009	US20090318456 Substituted pteridines for the treatment and prevention of viral infections
12/24/2009	US20090318452 INHIBITORS OF p38
12/24/2009	US20090318445 Pdf inhibitors
12/24/2009	US20090318444 Tetrahydro- and dihydroquinazolinones
12/24/2009	US20090318431 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
12/24/2009	US20090318427 Benzodiazepine derivatives for treating hepatitis c infection
12/24/2009	US20090318421 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
12/24/2009	US20090318403 Antibiotic composition
12/24/2009	US20090318379 Statins for the Treatment of Viral Influenza Infections
12/24/2009	US20090318378 Antibiotic Combinations For Providing Total Solution to the Treatment of Infections
12/24/2009	US20090318375 Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
12/24/2009	US20090318358 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
12/24/2009	US20090318342 Compounds
12/24/2009	US20090317492 Therapeutic Composition and Use
12/24/2009	US20090317487 Kits for prevention and treatment of rhinitis
12/24/2009	US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii
12/24/2009	US20090317479 Nanoparticles containing water-soluble non-peptide low-molecular weight drug
12/24/2009	US20090317472 Controlled releases of actives in skin
12/24/2009	US20090317466 Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine
12/24/2009	US20090317424 Oral vaccines
12/24/2009	US20090317422 Use of ppd for the adjuvantation of a nucleic acid vaccine
12/24/2009	US20090317420 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
12/24/2009	US20090317418 Vaccines and methods for prevention and treatment of drug-resistant hiv-1 and hepatitis b virus
12/24/2009	US20090317417 Modified AAV Vectors Having Reduced Capsid Immunogenicity and Use Thereof
12/24/2009	US20090317415 Hpv vaccine comprising peptides from host cell proteins
12/24/2009	US20090317412 Induction of an immune response against streptococcus pneumoniae polyaccharides
12/24/2009	US20090317408 Ligand conjugated thermotherapy susceptors and methods for preparing same
12/24/2009	US20090317395 Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP)

1 ... 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 ... 1798